What’s New and Updates/Changes

New Panel Member
Tuesday, April 28, 2015

We are pleased to announce a new member to the HCV Guidance Panel! Tracy Swan is the Hepatitis/HIV Project Director for Treatment Action Group, and joins the Panel as a Community Representative.

New Panel Member
Thursday, April 16, 2015

We are pleased to announce a new member to the HCV Guidance Panel! Andrew Reynolds is the Hepatitis C Education Manager of Project Inform, and joins the Panel as a Community Representative.

ION-4 Study Correction in Coinfection
Thursday, April 9, 2015

A correction has been made to a typographical error in the description of the ION-4 study, in the ‘Unique Populations: Patients with HIV/HCV Section’ with regard to not recommending a shortened ledipasvir/sofosbuvir treatment course for HIV/HCV coinfected individuals.

DDI with Amiodarone
Wednesday, April 8, 2015

A recent FDA alert warns against combining amiodarone with ledipasvir/sofosbuvir or with sofosbuvir taken in combination with another direct acting antiviral. This interaction has been added to the ‘Drug Interaction With Direct-Acting Antivirals and Selected Concomitant Medications’ table in the Initial Treatment section.

Coinfection Section Updated
Friday, March 13, 2015

The Coinfection section of the HCV Guidance has been updated to incorporate new data from the 2015 Conference on Retroviruses and Opportunistic Infections held from February 23-26, 2015.  Abstracts and webcasts from the conference can be accessed from the IAS-USA website.

Pages